# OnCo record nct03990896 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03990896/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03990896", "NCT03990896" ;
  schema:name "Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial"@en ;
  schema:description "This study tests a PARP inhibitor; the registry reports that it is recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03990896/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03990896> ;
  onco:status "recruiting" ;
  onco:phase "2" ;
  schema:startDate "2021-11-18" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/talazoparib/> .